Stephanie E.Parker

Practice Leader Business & Tort Litigation

(T) + 1.404.581.8552

Stephanie Parker co-leads the Firm's Business & Tort Litigation Practice and oversees the product liability litigation practice. She has extensive experience trying and leading "bet the company" litigation, especially product liability and mass tort cases. She led the team that achieved the record-breaking patent infringement verdict for Idenix Pharmaceuticals (subsidiary of Merck & Co.), the largest infringement verdict in U.S. history. After a two-week trial, the jury ordered Gilead Sciences to pay $2.54 billion in damages. Stephanie was named "Litigator of the Week" by The AmLaw Litigation Daily for Idenix's patent victory.

Stephanie has served clients in the tobacco, chemical, gasoline, pharmaceutical, medical device, and automotive industries. She also has significant other litigation experience, ranging from banking to white-collar criminal matters to the First Amendment. For more than 10 years, Stephanie has served as lead trial counsel for R.J. Reynolds Tobacco Company in smoking and health-related jury trials. Currently, she is lead counsel for R.J. Reynolds in its Engle progeny litigation in Florida, which involves more than 9,000 plaintiffs. In this role, she has tried every bellwether trial in the Engle litigation: she was the lead defense lawyer in Reynolds' first state court trial, which resulted in the first ever Engle defense verdict for the industry; she was the lead defense lawyer in the first Engle federal court case, which also resulted in a defense verdict; and she has made many significant legal arguments on behalf of Reynolds.

Video

Experience

  • R.J. Reynolds wins complete defense verdict reversing $23.4 billion punitive damages awardOn June 24, 2019, following eleven days of trial, a jury in Pensacola, Florida returned a defense verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a retrial of a wrongful death action.
  • Merck obtains unanimous Supreme Court ruling in Fosamax® product liability caseJones Day represented Merck Sharp & Dohme Corp. in its unanimous win before the Supreme Court in a product liability case involving Merck's prescription medicine Fosamax®.
  • R.J. Reynolds wins complete defense verdict in Massachusetts wrongful death lawsuitOn March 27, 2019, following nearly four weeks of trial, a jury in state court in Dedham, Massachusetts returned a defense verdict in favor of Jones Day client, R.J. Reynolds Tobacco Company, in a wrongful death case.
  • R.J. Reynolds wins complete defense verdict in Russell wrongful death lawsuitOn January 25, 2019 after a trial lasting 15 days, a jury in Lakeland, Florida returned a complete defense verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a wrongful death action.
  • R.J. Reynolds wins complete defense verdict in Ellis "Engle progeny" lawsuitOn December 7, 2018, following ten days of trial, a jury in Tampa, Florida returned a defense verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a wrongful death action.
  • R.J. Reynolds wins complete defense verdict in Hochreiter wrongful death lawsuitOn November 16, 2018, after a trial lasting 11 days, a jury in Orlando, Florida returned a complete defense verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a wrongful death action.
  • Idenix wins $2.54 billion jury verdict in Gilead patent dispute involving hepatitis C drugsAfter a nine day trial and less than two hours of jury deliberation, Jones Day, on behalf of Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co.), won the largest patent infringement verdict in U.S. history to date, involving a multi-billion dollar patent dispute with Gilead Sciences Inc. over sofosbuvir, the active ingredient in Gilead’s hepatitis C drugs Sovaldi® and Harvoni®.
  • R.J. Reynolds wins complete defense verdict in Morales personal injury suitOn August 22, 2018, following seven days of trial, a state court jury in Miami, Florida returned a unanimous defense verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a personal injury lawsuit.
  • Drug manufacturer defends against public nuisance and related tort and statutory claims in prescription opiate MDL and state court proceedingsJones Day is defending a major drug manufacturer against public nuisance and related tort and statutory claims asserted in actions consolidated for pretrial proceedings in In re: National Prescription Opiate Litigation, No. 1:17-MD-2804 (N.D. Ohio), as well as in analogous state court actions in Arkansas, New Jersey, Nevada, Pennsylvania, and Texas.
  • R.J. Reynolds wins complete defense verdict in Damiano personal injury lawsuitOn May 23, 2018, after a trial lasting 11 days, a jury in Sarasota, Florida returned a complete defense verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a personal injury lawsuit.
  • R. J. Reynolds obtains order dismissing 1,250 "Engle progeny" lawsuits and sanctioning plaintiffs' attorneysJones Day represents defendant R.J. Reynolds Tobacco Company in many "Engle progeny" cases, including all the ones pending in federal court."
  • R.J. Reynolds wins complete defense verdict in Jones wrongful death lawsuitOn August 23, 2017, after a trial lasting more than three weeks, a state court jury in Vero Beach, Florida returned a unanimous defense verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a wrongful death lawsuit.
  • R.J. Reynolds obtains decision overturning FDA's attempt to impose preapproval requirements for many label changesOn behalf of R.J. Reynolds Tobacco Company and related entities, Jones Day and its co-counsel persuaded the court to invalidate the U.S. Food and Drug Administration's effort to impose preapproval requirements for many changes to labels and brand names for tobacco products.
  • R.J. Reynolds wins complete defense verdict in Durrance "Engle progeny" trialOn February 8, 2017, Jones Day client R.J. Reynolds Tobacco Company received a complete defense verdict in a wrongful death action.
  • R.J. Reynolds wins jury verdict in Kloppenburg "Engle progeny" trialOn November 14, 2016, following 10 days of trial, a jury in Naples, Florida returned a complete defense verdict for Jones Day client R.J. Reynolds Tobacco Company in a personal injury action.
  • R.J. Reynolds wins new trial in "Engle progeny" lawsuitSitting en banc, Florida's Fourth District Court of Appeal recently granted rehearing and reversed a judgment in the amount of $16.1 million in compensatory damages (awarded jointly and severally against all four defendants), $29.85 million in punitive damages against Jones Day client R.J. Reynolds Tobacco Company and Lorillard Tobacco Company (which have since merged), and $25 million in punitive damages against the other two defendants.
  • R.J. Reynolds wins jury verdict in Coursey "Engle progeny" trialOn August 25, 2016, following nine days of trial, a jury in Deland, Florida returned a verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a personal injury action.
  • R.J. Reynolds prevails in U.S. Supreme Court on geographic scope of Civil RICOJones Day successfully represented the petitioners in a major U.S. Supreme Court decision restricting the extraterritorial application of the Racketeer Influenced and Corrupt Organizations Act (RICO).
  • R.J. Reynolds resolves long-running class action over unfair competition claimsJones Day client R.J. Reynolds Tobacco Company obtained a settlement resolving a nationwide consumer class action involving consumer promotional programs. R.J. Reynolds originally obtained dismissal of the case under Rule 12.
  • R.J. Reynolds wins jury verdict in Dupre "Engle progeny" trialJones Day client R.J. Reynolds Tobacco Company obtained a complete defense verdict in an "Engle progeny" case in which the plaintiff alleged her husband, Richard Dupre, had died at age 45 due to being addicted to R.J. Reynolds' cigarettes.
  • Additional Publications

    • December 20, 2016
      ATL Lawyer Who Led $2.548 Patent Win Had Never Tried an IP Case, Daily Journal (interviewed)
    • December 15, 2016
      Idenix Wins $2.5B Verdict In Gilead Hep C Drug Patent Fight, Law360 (interviewed)
    • May 2016
      Trial Pros: Jones Day's Stephanie Parker, Law360
    • January 2016
      Jury Clears RJR in $14M Row Over Pharmacy Tech's Death, Law360
    • November 2015
      Product Liability MVP: Jones Day's Stephanie Parker, Law360
    • August 2015
      Trial Aces: Jones Day's Stephanie Parker, Law360
    • April 2015
      How Top Product Liability Defenders Sway Jurors, Law360
    • November 2014
      Product Liability MVP: Jones Day's Stephanie Parker, Law360

    Speaking Engagements

    • November 5, 2015
      Becoming First Chair, Defense Research Institute
    • September 5, 2014
      Class Actions, Georgia ICLE
    • September 18, 2009
      Trial Techniques
    • October 6, 2006
      Class Actions
    • November 11, 2005
      Successful Trial Practices - Cross Examination, Georgia ICLE
    • October 7, 2005
      Class Actions - Expert Witness Testimony at the Class Certification Hearing
    • October 14, 2004
      Class Actions - Product Liability, Georgia ICLE
    • August 7, 2004
      New Frontiers in Product Liability Litigation, American Bar Association Annual Meeting, Presidential CLE Program
    • June 11, 2004
      Cross Examination, Defense Research Institute
    • February 21, 2003
      Successful Trial Techniques, Georgia ICLE
    • December 13, 2002
      Trial Techniques in Product Liability Cases - New Ideas and Proven Strategies, Georgia ICLE
    • March 28, 2002
      Successful Trial Techniques, Georgia ICLE
    • November 1, 2001
      Professional and Ethical Dilemmas in Litigatiion, Georgia ICLE
    • December 7, 2000
      Nuts & Bolts of Product Liability Law, cochair, Georgia ICLE
    • June 9, 2000
      Ninth Annual Product Liability Seminar, chair, Georgia ICLE
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.